Giuseppe Privitera

6PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesAutoimmunityPredictive and prognostic markersImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 21, 2023
Comparison of two strategies for the management of postoperative recurrence in Crohn's disease patients with one clinical risk factor: A multicentre IG-IBD study.

Gabriele Dragoni, Fabiana Castiglione, Cristina Bezzio

|Feb 13, 2023
The gasdermin protein family: emerging roles in gastrointestinal health and disease.

Giuseppe Privitera, Nitish Rana, Alessandro Armuzzi

|Sep 26, 2022
A rare case of epiploic appendagitis in a patient affected by ulcerative colitis on vedolizumab therapy.

Daniela Pugliese, Giuseppe Privitera, Luigi Larosa

|Apr 29, 2022
Live or let die: Translational insights and clinical perspectives of gasdermin B-dependent intestinal epithelial cell fate.

Giuseppe Privitera, Theresa T Pizarro

|Mar 11, 2021
Dual Targeted Therapy in Patient With Extensive Crohn's Disease: Different Response at Distinct Location.

Giuseppe Privitera, Daniela Pugliese, Alessandro Armuzzi

|Nov 18, 2020
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study.

Daniela Pugliese, Giuseppe Privitera, Francesca Rogai

Pageof 1